Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 155,852 shares at $10.86 ($1.7M) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($1.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.86 | 77,926 | $846K | 50.0% |
| 2 | $10.86 | 77,926 | $846K | 50.0% |
| Total | $10.86 avg | 155,852 | $1.7M | 100% |
| Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |
| FOLD | SELL | 2025-02-21 | $4K | — | Filing → |